Thyroiditis, unspecified (E06.9) is a clinical designation for inflammation of the thyroid gland when the specific underlying etiology or clinical variant has not been identified or documented. The thyroid is a vital endocrine gland located in the lower anterior neck that regulates metabolism through the production of thyroxine (T4) and triiodothyronine (T3). Inflammation of this gland can lead to a variety of metabolic disturbances, often presenting in a triphasic pattern: an initial thyrotoxic phase (caused by the leakage of preformed hormones into the bloodstream), a subsequent hypothyroid phase (occurring as hormone stores are exhausted and the glandular tissue is damaged), and an eventual euthyroid (recovery) phase. This code is often utilized in early diagnostic stages when the clinician observes symptoms of thyroid inflammation—such as neck pain, tenderness, or abnormal thyroid function tests—but has not yet differentiated between specific forms such as Hashimoto's thyroiditis, subacute granulomatous thyroiditis, or silent thyroiditis. Diagnostic evaluation typically involves measuring thyroid-stimulating hormone (TSH), free T4, and thyroid antibodies (TPO or TgAb), and may include ultrasound or radioactive iodine uptake (RAIU) scans to determine the specific inflammatory process.
Distinguish between acute, subacute, and chronic thyroiditis to move beyond the unspecified E06.9 code.
Example: Patient presents with sudden onset of anterior neck pain and fever following a recent viral upper respiratory infection. Physical exam reveals a firm, exquisitely tender thyroid gland. Laboratory studies show an elevated erythrocyte sedimentation rate and suppressed TSH. Plan: Prescribe NSAIDs for subacute thyroiditis. Billing Focus: Clinical presentation suggests subacute etiology. Risk Adjustment: This identifies a specific inflammatory process rather than a general thyroid disorder.
Billing Focus: Identify the underlying cause such as viral, bacterial, or autoimmune to assign a more specific code.
Document the current functional status of the thyroid gland, including thyrotoxicosis or hypothyroidism.
Example: Patient with known chronic thyroiditis now presenting with palpitations, heat intolerance, and tremors. TSH is 0.01 uIU/mL with elevated Free T4. Diagnosis: Chronic thyroiditis with transient thyrotoxicosis. Plan: Start propranolol for symptom management. Billing Focus: Inclusion of functional status (thyrotoxicosis). Risk Adjustment: Concurrent functional disorders increase the complexity of the medical decision-making process.
Billing Focus: Link functional status (e.g., hyperthyroid or hypothyroid) to the thyroiditis diagnosis.
Identify and document autoimmune markers such as Anti-TPO or Anti-TG antibodies.
Example: Evaluation of asymptomatic goiter. Labs positive for high titers of thyroid peroxidase antibodies. TSH slightly elevated at 6.5. Assessment: Hashimoto thyroiditis with subclinical hypothyroidism. Billing Focus: Positive antibody titers support an autoimmune thyroiditis diagnosis (E06.3). Risk Adjustment: Autoimmune status classifies the condition as a chronic systemic disease.
Billing Focus: Use laboratory evidence to support specificity beyond unspecified thyroiditis.
Specify if the thyroiditis is related to pregnancy or the postpartum period.
Example: Patient 4 months postpartum complaining of fatigue and hair loss. TSH is 12.5. Diagnosis: Postpartum thyroiditis, hypothyroid phase. Billing Focus: Temporal relationship to childbirth. Risk Adjustment: This identifies a condition specific to the obstetric history and potential for recurrence in future pregnancies.
Billing Focus: Document the postpartum status to assign code E06.5 or O90.5 depending on the payer preference.
Note any medication-induced etiologies, particularly with Lithium, Amiodarone, or Checkpoint Inhibitors.
Example: Patient on Amiodarone for atrial fibrillation. Routine monitoring shows new onset thyroid dysfunction. Diagnosis: Drug-induced thyroiditis. Plan: Consultation with Cardiology regarding medication alternatives. Billing Focus: External cause reporting (T code for the drug). Risk Adjustment: Identifies iatrogenic complications and high-risk medication monitoring requirements.
Billing Focus: Associate the thyroiditis with the specific causative agent using an additional external cause code.
Typically used for routine thyroid function test reviews and medication adjustments.
Used when managing thyroiditis requires complex medication adjustments or evaluation of new symptoms.
The primary diagnostic test for assessing thyroid function in cases of thyroiditis.
Essential for determining the severity of hyperthyroidism or hypothyroidism associated with thyroiditis.
Used to confirm an autoimmune etiology for the thyroiditis.
Used to evaluate thyroid structure, detect nodules, or assess inflammatory changes.
Helps differentiate between subacute thyroiditis (low uptake) and Graves disease (high uptake).
Occasionally necessary if a nodule is present or to rule out lymphoma in Riedel thyroiditis.
Secondary antibody test to support a diagnosis of autoimmune thyroiditis.
Required for a comprehensive initial workup of an undiagnosed thyroid condition.